Investors Become Goldilocks in a Bear Market

<p>Current market trends have put investors in a “flight-to-safety” mentality, especially when it comes to biotech companies. What does this mean for getting biotech innovations to the marketplace? This episode explores the daunting challenge of raising capital in a bear market.</p><p><strong>Speakers:</strong></p><ul><li><strong>Bill Newell, Sutro Biopharma</strong></li><li><strong>Dr. Lisa Drakeman, Biotech Entrepreneur</strong></li><li><strong>Sougato Das, PRISM.science</strong></li></ul><p> </p>